Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral

Endorsed by the BSG Liver Section


Liver disease, of which liver cirrhosis is the most advanced stage, constitutes the fourth most common cause of life-years lost in men and women younger than 75 years in England, where mortality rates from liver disease have increased by 25% in the past decade. Alcohol consumption is the most common modifiable risk factor for disease progression in these individuals, but within the UK, there is substantial variation in the distribution, prevalence, and outcome of alcohol-related liver disease, and no equity of access to tertiary transplantation services. These revised recommendations were agreed by an expert panel convened by the UK Liver Advisory Group, with the purpose of providing consensus on referral for transplant assessment in patients with alcohol-related disease, and clarifying the terminology and definitions of alcohol use in liver injury. By standardising clinical management in these patients, it is hoped that there will be an improvement in the quality of care and better access to liver transplant assessment for patients with alcohol-related liver disease in the UK.

 

Masson S, Aldersley H, Leithead JA, Day E, Langford A, Healy P, O’Grady J, Thorburn D, Parker C, Shepherd L, Arndtz K, Webb K, Holt A.

Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral.

Lancet Gastroenterol Hepatol. 2021 Nov;6(11):947-955; doi: 10.1016/S2468-1253(21)00195-3

Read More

BSG logo
Guidance
Clinical Resources Area
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer
clinical-resource/Acute-chronic-gastrointestinal-symptoms-cancer
Survival rates after a diagnosis of cancer are improving. Poorly managed gastrointestinal (GI) side effects can interfere with delivery of curative cancer treatment. Long-term physical side effects of

BSG logo
Clinical Resources
Guidance
Ramadan intermittent fasting for patients with gastrointestinal and hepatobiliary diseases: practical guidance for health-care professionals
clinical-resource/Ramadan-intermittent-fasting-for-patients
This Guidance was published in February 2025.